Neuroscience

Ongoing advances in our understanding of the Central Nervous System (CNS) promise to improve treatment options for a wide variety of diseases and dysfunctions, ranging from Alzheimer’s Disease and Parkinson’s Disease to anxiety and depression.

The pursuit of novel therapeutics to address these critical challenges can be supported by high-quality experimental data across all stages of drug discovery and development. All of our screening and proteomic services can be leveraged to advance neuroscientific research, providing valuable insights into target and disease biology, therapeutic leads, and global effects of drug treatment.

Our team has experience in neuronal cell culture, enabling us to effectively support preclinical neuroscience research. We can also provide access to proprietary protein turnover data from brain-derived cell lines (Protein Turnover Atlas™) as well as in vivo turnover data from murine brain, cerebellum, and other relevant tissues (Mouse Turnover Atlas™).